Invivogen
Menu

InvivoGen's product citations

Citations

InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).

Citations search

You can search by ‘Product Name’ or ‘Year’.

Find a citation by product name
Enter a year of publication
Product Citation Year Journal Authors Page
Zeocin® High Glucose Induces in HK2 Kidney Cells an IFN-Dependent ZIKV Antiviral Stat... 2022 Biomedicines Reslan A. et al. DOI: 10.3390/biomedicines10071577
Poly(I:C) LMW Spermidine reduces neuroinflammation and soluble amyloid beta in an Alzheimer... 2022 J Neuroinflammation Freitag K. et al. DOI: 10.1186/s12974-022-02534-7
NLRP3 inflammasome inhibitor - MCC950 Spermidine reduces neuroinflammation and soluble amyloid beta in an Alzheimer... 2022 J Neuroinflammation Freitag K. et al. DOI: 10.1186/s12974-022-02534-7
Puromycin Cancer-targeted photoimmunotherapy induces antitumor immunity and can be augm... 2022 Cancer Immunol Immunother. Hsu M.A. et al. DOI: 10.1007/s00262-022-03239-9
Puromycin circFBXO7/miR-96-5p/MTSS1 axis is an important regulator in the Wnt signaling... 2022 Mol Cancer Wu M. et al. DOI: 10.1186/s12943-022-01611-y
Zeocin® Exploring the Utility of Recombinant Snake Venom Serine Protease Toxins as Im... 2022 Toxins (Basel) Alomran N. et al. DOI: 10.3390/toxins14070443
Puromycin Genome-Wide CRISPR Screening Identifies DCK and CCNL1 as Genes That Contribut... 2022 Cancers (Basel) Yang H. et al. DOI: 10.3390/cancers14133152
Blasticidin Genome-Wide CRISPR Screening Identifies DCK and CCNL1 as Genes That Contribut... 2022 Cancers (Basel) Yang H. et al. DOI: 10.3390/cancers14133152
IL12elasti (p35::p40) Systemically targeted cancer immunotherapy and gene delivery using transmorph... 2022 EMBO Mol Med Asavarut P. et al. DOI: 10.15252/emmm.202115418
QUANTI-Luc™: Luciferase Detection Reagent Systemically targeted cancer immunotherapy and gene delivery using transmorph... 2022 EMBO Mol Med Asavarut P. et al. DOI: 10.15252/emmm.202115418
IL15 Systemically targeted cancer immunotherapy and gene delivery using transmorph... 2022 EMBO Mol Med Asavarut P. et al. DOI: 10.15252/emmm.202115418
TNF Systemically targeted cancer immunotherapy and gene delivery using transmorph... 2022 EMBO Mol Med Asavarut P. et al. DOI: 10.15252/emmm.202115418
IL17RD Thymoquinone upregulates IL17RD in controlling the growth and metastasis of t... 2022 BMC Cancer Khan M.A. et al. DOI: 10.1186/s12885-022-09782-z
MPLA Synthetic VacciGrade™ Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust an... 2022 J Immunother Cancer Lee W.S. et al. DOI: 10.1136/jitc-2022-004799
ODN 2395 VacciGrade™ Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust an... 2022 J Immunother Cancer Lee W.S. et al. DOI: 10.1136/jitc-2022-004799
MDP The NOD/RIPK2 signaling pathway contributes to osteoarthritis susceptibility. 2022 Ann Rheum Dis. Jurynec M.J. et al. DOI: 10.1136/annrheumdis-2022-222497
Blasticidin Culture media selection and feeding strategy for high titer production of a l... 2022 Bioprocess Biosyst Eng. Shen C.F. et al. DOI: 10.1007/s00449-022-02737-5
Blasticidin Exploring antiviral and anti-inflammatory effects of thiol drugs in COVID-19. 2022 Am J Physiol Lung Cell Mol Physiol Khanna K. et al. DOI: 10.1152/ajplung.00136.2022
Puromycin SARS-CoV-2 ORF8 reshapes the ER through forming mixed disulfides with ER oxid... 2022 Redox Biol. Liu P. et al. DOI: 10.1016/j.redox.2022.102388
Puromycin In Silico Discovery and Optimisation of a Novel Structural Class of Hsp90 C-T... 2022 Biomolecules Zajec Ž. et al. DOI: 10.3390/biom12070884

Pages

Customer Service
& Technical Support
Contact us
Shopping cart is empty